EX-23.1 2 exhibit231_consent.htm EXHIBIT 23.1 CONSENT exhibit231_consent.htm
 
EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm



The Board of Directors
 
Cytori Therapeutics, Inc.:
 
We consent to the incorporation by reference in the registration statements (Nos. 333-82074 and 333-122691) on Form S-8 and (Nos. 333-159912, 333-140875, 333-157023, 333-153233, 333-134129, 333-157023, and 333-169822) on Form S-3 of Cytori Therapeutics, Inc. of our reports dated March 11, 2011, with respect to the consolidated balance sheets of Cytori Therapeutics, Inc. and subsidiaries as of December 31, 2010 and 2009, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2010, the accompanying schedule of valuation and qualifying accounts, and the effectiveness of internal control over financial reporting of Cytori Therapeutics, Inc. and subsidiaries as of December 31, 2010, and to the reference to our firm in Item 6, Selected Financial Data, which reports and reference to our firm appears in the December 31, 2010, annual report on Form 10-K of Cytori Therapeutics, Inc.
 
/s/ KPMG LLP
 

 
San Diego, California
 
 
March 11, 2011